IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Idiopathic Inflammatory Myositis
Royal Brompton & Harefield NHS Foundation Trustmonoclonal_antibodyPhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 46/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Idiopathic Inflammatory Myositis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Cyclophosphamide Tongji Hospital | Phase 2/3 | BB |
Universal Cd19 Car-Γδt Cell Tongji Hospital | Phase 1 | CC |
Fludarabine Tongji Hospital | Phase 1 | CC |
RD06-05 CART Cell The Children's Hospital of Zhejiang University School of Medicine | Early Phase 1 | C |
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →